Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1900
-0.0050 (-2.56%)
Aug 26, 2026, 4:10 PM AEST

Argenica Therapeutics Statistics

Total Valuation

ASX:AGN has a market cap or net worth of AUD 24.41 million. The enterprise value is 19.37 million.

Market Cap24.41M
Enterprise Value 19.37M

Important Dates

The next estimated earnings date is Friday, August 28, 2026.

Earnings Date Aug 28, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:AGN has 128.46 million shares outstanding. The number of shares has decreased by -3.06% in one year.

Current Share Class 128.46M
Shares Outstanding 128.46M
Shares Change (YoY) -3.06%
Shares Change (QoQ) -0.19%
Owned by Insiders (%) 19.31%
Owned by Institutions (%) 9.52%
Float 97.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.28
PB Ratio 4.13
P/TBV Ratio 4.14
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.40
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.60

Current Ratio 10.60
Quick Ratio 10.51
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4,361.18

Financial Efficiency

Return on equity (ROE) is -20.78% and return on invested capital (ROIC) is -12.99%.

Return on Equity (ROE) -20.78%
Return on Assets (ROA) -9.72%
Return on Invested Capital (ROIC) -12.99%
Return on Capital Employed (ROCE) -23.13%
Weighted Average Cost of Capital (WACC) 8.40%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.65
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -72.06% in the last 52 weeks. The beta is 0.75, so ASX:AGN's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change -72.06%
50-Day Moving Average 0.15
200-Day Moving Average 0.20
Relative Strength Index (RSI) 56.88
Average Volume (20 Days) 73,407

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:AGN had revenue of AUD 5.70 million and -1.37 million in losses. Loss per share was -0.01.

Revenue5.70M
Gross Profit 5.70M
Operating Income -1.37M
Pretax Income -1.37M
Net Income -1.37M
EBITDA n/a
EBIT -1.37M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 6.36 million in cash and no debt, with a net cash position of 6.36 million or 0.05 per share.

Cash & Cash Equivalents 6.36M
Total Debt n/a
Net Cash 6.36M
Net Cash Per Share 0.05
Equity (Book Value) 5.90M
Book Value Per Share 0.05
Working Capital 5.90M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.19M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -23.96% and -23.97%.

Gross Margin 100.00%
Operating Margin -23.96%
Pretax Margin -23.97%
Profit Margin -23.97%
EBITDA Margin n/a
EBIT Margin -23.96%
FCF Margin n/a

Dividends & Yields

ASX:AGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 3.06%
Shareholder Yield 3.06%
Earnings Yield -5.59%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a